Showing results (41-50 of 2,690) with videos related to
Sort By:
Pageof 269
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 15, 2005
Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much?Brendan Duffy, Deepak L BhattNature Reviews. Cardiology|June 3, 2010
Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherenceKumaran Kolandaivelu, Deepak L BhattInterventional Cardiology Clinics|November 26, 2016
Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary InterventionArjun Majithia, Deepak L BhattProgress in Cardiovascular Diseases|July 25, 2015
Culprit-Only vs. Complete Revascularization During ST-Segment Elevation Myocardial InfarctionArman Qamar, Deepak L BhattCurrent Opinion in Cardiology|September 17, 2019
Cardiometabolic risk reduction after metabolic surgeryManan Pareek, Deepak L BhattAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2016
Optimizing the Use of Cangrelor in the Real WorldArman Qamar, Deepak L BhattArchives of Internal Medicine|October 27, 2004
Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studiesJack Hirsh, Deepak L BhattNature Reviews. Cardiology|July 14, 2011
The evolution of antiplatelet therapy in cardiovascular diseaseOmair Yousuf, Deepak L BhattPharmacology & Therapeutics|January 24, 2016
Current status of data on cangrelorArman Qamar, Deepak L BhattArteriosclerosis, Thrombosis, and Vascular Biology|February 15, 2019
Novel Antiplatelet Therapies for Atherothrombotic DiseasesArjun Majithia, Deepak L BhattPageof 269